- Condition: Coronary Heart Disease
Interventions: Drug: Ethinyl Estradiol-Levonorgestrel combination; Drug: leuprolide acetate; Drug: Estradiol; Drug: Progesterone
Sponsors: Oregon Health and Science University; Oregon Health and Science University; Medical Research Foundation, Oregon
Recruiting - verified March 2012 - Condition: Endothelial Dysfunction
Intervention: Drug: Telmisartan
Sponsors: University of California, Los Angeles; University of California, Los Angeles; The Campbell Foundation
Not yet recruiting - verified April 2012 - Condition: Herpes Simplex Type II
Interventions: Drug: Tenofovir; Drug: placebo gel; Drug: tenofovir disoproxil fumarate (TDF); Drug: placebo tablets
Sponsors: University of Washington; University of Washington; CONRAD; Gilead Sciences
Recruiting - verified March 2012 - Conditions: Uterine Fibroids; Heavy Uterine Bleeding
Interventions: Drug: placebo; Drug: elagolix, elagolix sodium; Drug: Placebo; Drug: elagolix, elagolix sodium; Other: Elagolix Dose 1 plus estradiol/norethindrone acetate; Drug: Placebo Cohort 4; Drug: Elagolix, elagolix sodium; Drug: Elagolix, elagolix sodium
Sponsors: Abbott; Abbott; Neurocrine Biosciences
Recruiting - verified April 2012 - Conditions: Hyperandrogenemia; Polycystic Ovary Syndrome
Interventions: Drug: Progesterone; Drug: Estrace (estrogen)
Sponsors: University of Virginia; University of Virginia; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified August 2011 - Conditions: Polycystic Ovary Syndrome; Hyperandrogenism
Interventions: Drug: Metformin; Drug: Progesterone; Drug: estrace
Sponsors: University of Virginia; University of Virginia; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified August 2011 - Conditions: Polycystic Ovary Syndrome; Hyperandrogenism
Interventions: Drug: Flutamide; Drug: Progesterone; Drug: estrace (estradiol)
Sponsors: University of Virginia; University of Virginia; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified September 2011 - Conditions: Hot Flashes; Menopause; Vasomotor Disturbance
Interventions: Drug: Low-dose 17-ß-estradiol; Drug: Venlafaxine XR; Drug: Placebo
Sponsors: Fred Hutchinson Cancer Research Center; Fred Hutchinson Cancer Research Center; National Institute on Aging (NIA); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Center for Complementary and Alternative Medicine (NCCAM); Office of Research on Women's Health (ORWH)
Recruiting - verified December 2011 - Condition: Vaginosis, Bacterial
Intervention: Drug: Etonogestrel /Ethinyl Estradiol Contraceptive Vaginal Ring
Sponsors: Eastern Virginia Medical School; Eastern Virginia Medical School; Merck
Recruiting - verified April 2012 - Conditions: Estrogen Receptor-positive Breast Cancer; Progesterone Receptor-positive Breast Cancer; Recurrent Breast Cancer; Stage IIIC Breast Cancer; Stage IV Breast Cancer
Interventions: Biological: therapeutic estradiol; Drug: exemestane; Other: laboratory biomarker analysis; Other: enzyme-linked immunosorbent assay
Sponsors: University of Arizona; University of Arizona; National Cancer Institute (NCI)
Recruiting - verified May 2012 - Conditions: Obstructive Sleep Apnea; Enlargement of Tonsil or Adenoid
Interventions: Drug: Caffeine and sodium Benzoate 10 mg/kg IV; Drug: Caffeine and Sodium Benzoate 20 mg/kg IV; Drug: 0.9 NS Saline
Sponsors: The University of Texas Health Science Center, Houston; The University of Texas Health Science Center, Houston; Memorial Hermann Hospital
Recruiting - verified March 2012 - Conditions: Stage IIIB Non-small Cell Lung Cancer With Pleural Effusion; Stage IV Non-small Cell Lung Cancer
Interventions: Drug: Tamibarotene; Drug: Placebo
Sponsors: CytRx; CytRx
Recruiting - verified March 2012 - Conditions: Perimenopause; Menopause; Depression
Intervention: Drug: Estradiol
Sponsors: University of North Carolina, Chapel Hill; University of North Carolina, Chapel Hill; National Institute of Mental Health (NIMH)
Recruiting - verified February 2012 - Condition: Anorexia Nervosa
Interventions: Drug: RhIGF-1 with transdermal 17-beta estradiol; Drug: Placebo and transdermal 17-beta estradiol
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; The Hospital for Sick Children
Recruiting - verified February 2012 - Condition: Type 1 Diabetes
Interventions: Drug: Estradiol, medroxyprogesterone, hydrocortisone, growth hormone; Drug: Matching placebo
Sponsors: Sansum Diabetes Research Institute; Sansum Diabetes Research Institute
Not yet recruiting - verified July 2011 - Condition: Menopause
Interventions: Drug: estradiol transdermal system; Drug: Amino acid; Drug: Placebo Patch; Drug: Placebo
Sponsors: University of Pennsylvania; University of Pennsylvania; National Institute on Aging (NIA)
Recruiting - verified January 2012 - Condition: Menorrhagia
Interventions: Drug: Estradiol 30 mcg / Levonorgestrel 150 mcg monophasic oral contraceptive pills; Drug: Naproxen sodium pills; Device: Nova Sure Radiofrequency Endometrial Ablation
Sponsors: Mayo Clinic; Mayo Clinic; Hologic, Inc.
Recruiting - verified January 2012 - Condition: Orthostatic Intolerance
Interventions: Drug: 17 beta estradiol, progesterone, ganirelix acetate; Drug: 17 beta estradiol, progesterone, ganirelix acetate
Sponsors: Yale University; Yale University
Recruiting - verified August 2011 - Condition: Female Breast Cancer
Intervention: Drug: Estradiol
Sponsors: University of Wisconsin, Madison; University of Wisconsin, Madison
Recruiting - verified February 2012 - Conditions: Atrophic Vaginitis; Breast Cancer
Intervention: Drug: Vagifem® (vaginal 17β-estradiol) questionnaire & menopause symptom checklist
Sponsors: Memorial Sloan-Kettering Cancer Center; Memorial Sloan-Kettering Cancer Center
Recruiting - verified April 2012 - Conditions: Schizophrenia; Schizoaffective Disorder
Interventions: Drug: Telmisartan; Drug: Placebo
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; National Institutes of Health (NIH)
Recruiting - verified April 2012 - Condition: Exercise-related Amenorrhea
Interventions: Drug: Transdermal 17Beta-estradiol, progesterone; Drug: Ethinyl Estradiol + Desogestrel; Dietary Supplement: Elemental Calcium and Vitamin D
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified February 2012 - Condition: Premenstrual Dysphoric Disorder
Interventions: Drug: low dose oral contraceptive (20 ug ethinyl estradiol + 3 mg drospirenone); Drug: 20 ug ethinyl estradiol + 3 mg drospirenone; Drug: placebo
Sponsors: University of North Carolina, Chapel Hill; University of North Carolina, Chapel Hill
Recruiting - verified May 2012 - Condition: Acute Promyelocytic Leukemia
Intervention: Drug: Tamibarotene
Sponsors: CytRx; CytRx
Recruiting - verified March 2012 - Condition: Menopause
Interventions: Drug: Prempro, premarin, provera conjugated estrogens, medroxyprogesterone acetate; Drug: Estradiol , estriol , progesterone; Drug: estradiol,progesterone; Drug: estriol, progesterone
Sponsors: University of Kansas; Jeanne Drisko, MD, CNS, FACN; Private Foundation through KU Endowment; University of Kansas
Recruiting - verified September 2011 - Conditions: Postpartum Depression; Depression
Intervention: Drug: 17 beta-estradiol
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Mental Health (NIMH)
Recruiting - verified September 2011
 |
Benzoates Clinical Trials |
